Dianalitics
MFA Financial, Inc.
MFA · v1 · 2026-09-30
hourglass
Loading…
Preparing the latest DD data, styles and content.
64OpportunityDD: Sep 30, 2026Analyst: 60
paidPrice at analysis date
USD 8.05 (30/09/2026)
domainMkt cap
$819M
pie_chartShares
101.7M
candlestick_chart52W
$7.96-$10.43
trending_downShort interest
4.66%
MEDIUMNYSEReal Estate
Verdict: Asymmetric - NAV discount with mortgage-spread risk

MFA screens as an ASIMMETRIA candidate because the common stock trades near 0.61x Q2 economic book value, below recent lows, while buybacks below book and a lower-rate / tighter-spread path can re-rate the stock toward book. The independent DD does not underwrite full book value: the base fair value applies explicit credit, leverage and dividend-coverage haircuts.

DIANALITICS RESEARCH INDEX
Score /100 - updated 2026-09-30
60
MFA Financial, Inc.
Mortgage REIT, residential credit, Agency MBS and Non-QM loan portfolios
The setup is asset-backed and statistically cheap, but leverage, credit marks and dividend coverage keep this in high-monitoring territory rather than a clean quality rerating.
Fin. strength
12
/20 pts
EBITDA/FCF
8
/15 pts
Debt/leverage
6
/15 pts
Stage/business
13
/15 pts
Catalysts
8
/10 pts
Reg. risk
6
/8 pts
Risk/reward
5
/7 pts
Management
3
/5 pts
Sector/macro
2
/3 pts
Compliance
2
/2 pts
DISLOCATION0.61x EBVBUYBACK BELOW BOOKMREIT LEVERAGE
Base case fair value - economic book value bridge
Fair value base case
USD 11.7
Range: USD 6.60-USD 14.0
Price at analysis date: USD 8.05 (30/09/2026)
Base upside/downside: +45%

The nominal multiple is 0.90x economic book value. The implied fair value of $11.70 equals about 0.89x Q2 EBV after reserves, inside the peer range but below the $14 analyst target. Cross-check: a dividend-risk method using a 12% required yield on a reduced $1.20 annual dividend gives $10.00, within 15% of the base NAV result. Sensitivity: every 0.10x P/B change on $13.20 EBV moves FV by about $1.32/share. Not investment advice.

ComponentAssumptionUSD/share
Mortgage portfolio NAV anchor$13.20 Q2 2026 economic book value x 0.90x target P/B multiple+11.88
Credit and mark reserve-$75M base credit / spread reserve for Non-QM loans and securitized financing / 101.7M shares-0.74
Buyback accretion option$38M of the $190M remaining authorization executed at $8.25, value gap to $13.20 EBV spread over pro-forma shares+0.23
Dividend coverage reserve-$35M reserve because Q2 distributable earnings of $0.12/sh did not cover the $0.36 quarterly dividend / 101.7M shares-0.34
Rate / spread normalization option35% probability x (0.20x P/B rerating x $13.20 EBV) from Fed easing and tighter mortgage-credit spreads+0.92
FV base caseExplicit sum: 11.88 - 0.74 + 0.23 - 0.34 + 0.92 = $11.95; rounded down for model risk to $11.70$11.70
Bull
$13.20-$14.00
Probability: 25%
Economic book value stays stable, mortgage spreads tighten, buybacks continue below book and the market prices MFA at roughly 1.0x EBV.
Base
$11.70
Probability: 45%
The discount narrows only to 0.90x EBV, credit marks are manageable, and buyback accretion offsets part of the dividend-coverage concern.
Bear
$6.60-$7.40
Probability: 30%
Mortgage-credit marks widen, distributable earnings remain below dividend, and the market values MFA at 0.50x-0.56x economic book.
Methodology: The nominal multiple is 0.90x economic book value. The implied fair value of $11.70 equals about 0.89x Q2 EBV after reserves, inside the peer range but below the $14 analyst target. Cross-check: a dividend-risk method using a 12% required yield on a reduced $1.20 annual dividend gives $10.00, within 15% of the base NAV result. Sensitivity: every 0.10x P/B change on $13.20 EBV moves FV by about $1.32/share. Not investment advice. Not investment advice.
check_circle
Screening result - ASIMMETRIA / DISLOCATION
Selection gate: price $8.05, market cap about $819M, Q2 2026 economic book value $13.20 per share and GAAP book value $12.71. Floor used for screening is 0.50x economic book value, or $6.60 per share, implying about 18% downside from the verified price. Upside screen uses the recent analyst average target of $14.00 (+74%) as the re-rating path; screening ratio = 74% / 18% = 4.1x. The classification and ratio are selection criteria only; the fair value below is derived independently.
MFA was not present in the covered-ticker history.
Capital Structure - Short Interest - Buyback & Dilution
Short Interest
4.66%
4.66M shares short as of Aug. 31, 2026, about 4.66% of public float. This is low-to-moderate and not the core catalyst.
Share dilution (1Y)
-1.0%
Shares were about 102.7M in 2025 and about 101.7M at Q2 2026. Buybacks are mildly accretive below book.
Buyback
$190M left
$200M program authorized through 2028; $10M used in H1 2026 at about $9.72/share, with no common ATM issuance in H1.
Short Interest - context
MFA - 4.66%
4.66%

Governance/litigation check: targeted searches did not surface an active securities class action, short-seller report or SEC investigation for MFA in the last 12 months. The main capital-structure risk is not insider activity; it is mortgage REIT leverage, margin calls and the $300M ATM overhang, even though no common ATM shares were sold in H1 2026.

$Financial analysis - FY
Q2 GAAP net income
$36.2M
$0.34 diluted EPS
Economic book value
$13.20
Stable QoQ
Liquidity
$435M
Cash + unpledged Agency MBS
Recourse leverage
3.0x
Up from 2.5x at 2025YE
ItemFY2023FY2024FY2025FY2026E / latestGuidance / note
Interest income / revenue proxyN/DN/D$325.4M revenuePortfolio income sensitiveCredit spreads and funding costs drive net interest income
GAAP book value per shareN/D$13.80 YE$13.20 YE$12.71 Q2Book value is the valuation anchor
Economic book value per shareN/D$14.32 YE$13.75 YE$13.20 Q2Q2 total economic return 2.6%
Distributable earningsN/DN/DN/D$0.12/sh Q2$0.35/sh before realized credit losses
Common dividend$1.40-$1.44$1.44$1.44$0.36 quarterlyCoverage is the key risk
Quarterly dynamics - last 5 quarters
MetricQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026
GAAP BV / share13.1213.1313.20N/D12.71
Economic BV / share13.6913.6913.75N/D13.20
Net income / share0.21 dilutedN/DN/DN/D0.34 diluted
Liquidity ($M)N/DN/DN/D396.4435.3
NAV discount support
Strong
Dividend coverage
Weak
Funding flexibility
Mixed
account_tree

Business model - levered mortgage-credit balance sheet

The asset floor is visible, but not risk-free
MFA invests in residential whole loans, Non-QM mortgage loans, Agency MBS and securitized mortgage assets. The investment case is not revenue growth; it is whether a marked mortgage portfolio can preserve economic book value, fund the dividend, and retire shares below book while the rate cycle becomes less hostile.

Agency MBS $4.1B position liquid anchor Agency MBS rose to about 31% of the investment portfolio and gives the balance sheet more liquid collateral. Non-QM loans $462M Q2 purchases credit spread risk Non-QM assets support yield but create credit and mark sensitivity if housing or liquidity conditions worsen. Securitized debt $6.2B Q2 structural leverage Non-recourse securitized debt reduces recourse risk, but debt/net equity remains high at 6.6x.

gavel

Legal, regulatory and risk analysis

Book value marks
High
The thesis depends on economic book value holding near $13/share; wider mortgage spreads can reduce NAV quickly.
Dividend coverage
High
Q2 distributable earnings of $0.12/share were below the $0.36 quarterly dividend, though pre-credit-loss DE was $0.35/share.
NAV discount
Positive
The stock trades near 0.61x economic book, providing a clear valuation dislocation if book remains stable.
Buybacks below book
Positive
Repurchases at $9.72 in H1 were below both GAAP and economic book value and can be accretive if liquidity allows.
Leverage and margin calls
High
Debt/net equity is 6.6x and recourse leverage is 3.0x; funding stress is the main downside path.
ATM overhang
Medium
$300M remains available under the common-stock ATM, even though no shares were sold through it in H1 2026.
Governance / litigation
Low
No current class action, SEC investigation or short-seller report surfaced in targeted searches.
Rate cycle
Medium
Lower rates can help funding and book value, but curve volatility can still hurt hedges and MBS marks.
article

SWOT analysis

Strengths
  • +Economic book value of $13.20 provides a visible asset anchor.
  • +$435M of liquidity supports funding flexibility.
  • +The board has a large repurchase authorization through 2028.
Weaknesses
  • −Dividend coverage is weak on Q2 distributable earnings.
  • −Leverage is structurally high, as expected for the model.
  • −MFA remains exposed to mortgage-credit marks and funding spreads.
Opportunities
  • →A move from 0.61x to 0.90x economic book creates material upside.
  • →Buybacks below book can compound NAV per share.
  • →Lower-rate and tighter-spread conditions can lift book value confidence.
Threats
  • !Credit losses can keep distributable earnings below dividend.
  • !A housing or liquidity shock can push the stock toward 0.50x EBV.
  • !ATM issuance below book would damage the asymmetry.
article

Summary by assessment area

Valuation - Dislocated
  • 0.61x economic book is a real discount, not just a low P/E screen.
  • Base FV uses 0.90x EBV, below a full book-value recovery.
Risk - Levered
  • Debt/net equity and dividend coverage are the main reasons not to underwrite full book value.
  • The floor is marked-asset based, not cash based.
Catalyst - Macro + capital return
  • Q3/Q4 book value and distributable earnings are decisive.
  • Buybacks below book matter only if funding remains flexible.
Sources & Disclaimer

Sources: MFA Financial Q2 2026 results release and Q2 2026 10-Q; MFA Q2 2026 earnings-call transcript; StockAnalysis forecast and historical pages; Yahoo Finance MFA quote; Twelve Data historical table snippet; MarketBeat short-interest page; SEC 2026 filings on buyback and ATM program. Market data - last verified close 2026-09-29: MFA ~$8.05, market cap ~$819M, 52W range $7.96-$10.43, 101.7M shares outstanding. Short interest: 4.66M shares / 4.66% float / 2.69 days to cover as of Aug. 31, 2026. This document is for informational purposes only and does not constitute financial or investment advice.